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ABSTRACT 
BACKGROUND:   
Peridontitis is a chronic inflammatory disease that results in the 
destruction of the tooth supporting apparatus. It is believed to be mediated by 
the exaggerated host response that results from a disharmony between the pro 
inflammatory cytokine and anti inflammatory cytokine released during the 
inflammatory process. Recent advancements have enabled to detect the levels 
of proteins in oralfluids that may act as a bio marker for periodontal disease. 
This study was therefore conducted to assess the levels of salivary cytokines in 
patients with advanced periodontitis and healthy subjects. 
AIM:   
To analysis the levels of pro inflammatory cytokine TNF alpha and 
anti inflammatory cytokine IL-4 in saliva and serum and correlate it with the 
level of systemic cytokine hs-CRP in saliva and serum of chronic periodontitis 
patients and healthy subjects. 
MATERIALS AND METHODS:   
30 patients were included in the study. The study group was segregated 
as health group and chronic periodontitis group. Serum and saliva were 
collected from both the groups and the levels of TNF alpha and IL-4 was 
detected using ELISA. hs-CRP levels were detected using immunoturbidity  
method. Statistical analysis was done using independent sample student T test 
and Pearson correlation test. 
RESULTS:   
The levels of salivary TNF alpha in disease showed a statistical 
significance (P=0.035, P<0.05). There was a significant correlation between 
the salivary levels of hs-CRP and TNF alpha in serum (p<0.001). However the 
levels of both cytokine in saliva and serum were not significant. 
CONCLUSION:   
Chronic periodontitis may be mediated by the Th2 response and TNF 
alpha may be used as a bio marker for periodontal diseases as its level showed 
a significant increase in periodontitis. The nonspecific serum marker for 
systemic inflammation hs-CRP may be well correlated to the pro 
inflammatory cytokine TNF alpha than the anti-inflammatory marker IL-4. 
[key words: TNF alpha, IL-4, pro inflammatory cytokine, chronic 
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Periodontitis is a chronic inflammatory disorder that may eventually 
result in breakdown of the tooth supporting apparatus. It has also been 




  Microbial antigens present within the periodontal tissue initiate an 
inflammatory response in the host. The tissue destruction and disease 
progression that occurs in periodontal diseases is related to a prolonged but 
unprotected host response which may be mediated by genetic, environmental 
and systemic factors. This host response leads to a prolonged release of 
inflammatory mediators like kinins, eicasonoids, and cytokines.
84 
Pro 
inflammatory cytokines are linked to extensive tissue destruction while anti-
inflammatory cytokines counteract and attenuate disease progression. The 
imbalance between the pro inflammatory and anti-inflammatory cytokines 
may be an important determinant of periodontal disease progression.  
Tumor necrosis factor-alpha, a pro inflammatory cytokines is released 
from T cells, macrophages, cells of the junctional epithelium, connective 
tissue fibroblasts and polymorphonuclear leukocytes as a response of innate 
immunity.
114
 Prolonged production of TNF alpha results in excess bone 
resorption as it enhances osteoclastogenisis by up regulating RANK-RANKL 
coupling mechanism and by increasing the production of other pro 








IL-4 is generally considered as an anti-inflammatory cytokine as it 
suppresses the inflammatory function by inhibiting the transcription of pro 
inflammatory cytokine, suppressing the polarization of TH-1 cells and 
enhancing further production of other anti-inflammatory cytokines like IL-10.
3 
They also help to reduce the ongoing tissue degeneration process by inhibiting 
the production of RANKL & MMP’s and at the same time up regulating the 
expression of TIMP &OPG.
42
 
These inflammatory cytokines play an important role in the regulation 
of host response into Th1 or Th2 immune response in periodontal diseases. 
The balance between Th1 and Th2 cytokines regulate the immune response to 
infection. The overall effect of the Th1 cytokines is to enhance cell-mediated 
responses, while the effect of Th2 cytokine IL-4 is to suppress cell-mediated 
responses and enhance the resistance associated with humoral immunity.
67
 
There is a need for newer diagnostic tests that would help in early 
recognition of the microbial challenge, assessment of current disease activity, 
prediction of sites that are vulnerable for future breakdown and prediction of 
the periodontal therapy administered. Various researchers into this field are 
currently investigating the use of different oral fluids like saliva and GCF for 
diseases assessment.
62 
GCF may be regarded as a good diagnostic medium due to its 
proximity to the disease site but its difficulty in accurate volume 






multiple sampling of individual tooth reduces its efficacy as a diagnostic 
medium. 
  Saliva is an alternative diagnostic medium that acts as a noninvasive 
diagnostic aid to measure biomarkers released during disease initiation and 
progression.
49
 The localized nature and its proximity to periodontal lesions in 
the oral cavity, ready availability & ease in collection have increased the 
utilization of saliva as a natural biological fluid for measurement of microbial 
and protein biomarkers of the diseases process.
65 
Periodontal disease has been 
reported to influence the course of systemic diseases through the release of 
cytokines into circulation.
58
 Analysis of a systemic bio marker like hs-CRP in 
saliva would help in detection or assessment of any ongoing systemic 
inflammation in various chronic inflammatory conditions like diabetes 
mellitus, artherosclerosis . Hence this study aimed at a correlation between the 
levels of TNF alpha, IL-4 and hs-CRP in serum and saliva in both 
periodontitis patients and periodontaly healthy subjects. 
 





AIMS AND OBJECTIVES 
The aims of the present study are: 
1. To evaluate the salivary level of the pro inflammatory cytokine TNF 
alpha and the anti-inflammatory cytokine IL-4 in healthy subjects and 
in patients with chronic periodontitis.  
2. To evaluate the circulatory levels of TNF alpha and IL-4 in periodontal 
health and disease. 
3. To correlate salivary and serum levels TNF alpha and IL-4 in both 
periodontal health and disease. 
4. To correlate levels of the salivary and serum cytokines (TNF alpha & 
IL-4) and levels of hs-CRP in periodontal diseases. 





REVIEW OF LITRATURE 
PATHOGENISIS OF PERIODONTITIS 
The progression of gingivitis to periodontitis is a slow process that 
occurs as loss of attachment over a long period of time and also this result in 
rapid attachment loss that occurs in episodic burst in short time.
103 
It is now 
evident that periodontal diseases in humans has heterogeneous etiologies 
stemming from the development of biofilm in the subgingival environment 
,social and behavioral factors and genetic or epigenetic traits, all of which are 
modulated and controlled by the underlying immune and inflammatory 
responses of the host. As a result of biofilm maturation, the pathogenic species 
developing in the periodontal pockets release an assay of virulence factors, 
antigens, or by products that evade the host defense mechanism, causing 
damage to cells and tissue via dysregulated inflammatory interactions, which 
typically consists of neutrophil, monocytes/macrophages, dentritic cells,                  
T-cells and predominantly immunoglobulin producing B-cells.
85
 The infected 
tissue/cells are overwhelmed by persistent pathogens accompanied with a 
lasting chronic inflammation where the potent pro inflammatory mediators 
and cytokines prevail. Inflammation is a characteristic feature that depicts the 
trigger of the defense mechanism against an invading pathogen in the body 
which is accompanied by a release of many cytokines. 





Mahanonda R et al suggested that a critical aspect of the host 
response is the detection of bacteria by Toll-like receptors (TLRs).
61
 
Activation of the innate immune response by the binding of various bacterial 
components (i.e., diacyllipopeptides, peptidoglycan, LPS, flagellin, and 
bacterial DNA) to TLRs results in the production of cytokines and 
chemokines. Upon activation of TLRs, an intracellular signaling cascade is 
stimulated that leads to the activation of transcription factors (e.g., nuclear 
factor-kappa B, activator protein 1 (AP-1) and p38) and the production of 
various cytokines, many of which directly or indirectly stimulate osteoclast 
formation. 
  Evidence that cytokines played a critical role was shown in a non-
human primate model. In this report, inhibition of interleukin (IL)-1 and tumor 
necrosis factor (TNF) reduced the progression of periodontal bone loss and 
loss of attachment, which was attributed to the recruitment of inflammatory 
cells (notably monocytes and lymphocytes) toward the bone.
40 
Cytokines are low molecular protein involved in initiation and effector 
stages of immunity and inflammation, in which they regulate the amplitude 
and duration of the response. They are the cell regulators that have a major 
influence on the production and activation of different effector cells which 
decides the type of immune response that occurs on exposure to a pathogen 
which is in turn is vital in determining resistance or susceptibility to diseases. 
Cytokines interact with specific cell surface receptors which are usually 





expressed in relatively low numbers. Many cytokines are pleiotrophic, having 
multiple activation on different target cells and or overlapping cell regulatory  
actions. But despite this overlap cytokine function may be identical6. 
Cytokines interact in a network firstly by inducing each other, secondly, trans 
modulating cell surface receptors and thirdly, by a synergistic, additive or 
antagonistic interaction on cell function.
9 
PRO AND ANTI INFLAMMATORY CYTOKINES 
Kelso et al suggested that a successful immune response to an 
infectious agent depends on activation of appropriate effector functions.
51
 As 
periodontitis is a chronic inflammatory disease, it is certainly reasonable that 
such a condition establishes a local cytokine environment that influences the 
immune response. It is becoming increasingly clear, however, that cytokines 
do not function in isolation, but rather in complex networks involving both 
pro- and anti-inflammatory effects. Production of appropriate cytokine is 
essential for the development of protective immunity. If inappropriate 
cytokines is elicited destructive or progressive disease can result. 
The extent of periodontal tissue destruction is mainly determined by 
the balance maintained between the pro- and anti- inflammatory cytokines and 
the regulation of their receptor and signaling pathways. Pro inflammatory 
cytokines mediate the tissue damage, which leads to loss of function and 
clinical disease. The persistent activation of immune responses leads to 





increased synthesis and secretion of these pro inflammatory cytokines with 
concomitant effects on function and turnover of periodontal cells. 
 
Fig 1: release of protective and non-protective cytokine 
Snyderman R et al, suggested that periodontitis has high levels of 
proinflammatory cytokines, including IL-1b and tumor necrosis factor-alpha 
(TNF-alpha) and low levels of cytokines which suppress the 
immunoinflammatory response such as IL-10 and IL-4.
102
 These cytokines are 
associated with the active stages of periodontitis.  
Kawai and Akaira et al found that these cytokines (TNF alpha and 
IL-1β) are synthesized by the activation of transcription factor NF-ƙB which is 
activated by the recognition of LPS by a macromolecular complex involving 
CD14, MD-2 and TLR-4.
50 





Tumour necrosis factor-a (TNF-a) is one among the  pro-inflammatory 
cytokines that induces bone resorption and leads to  up regulated production of  
prostaglandin E2 (PGE2) and MMP secretion. 
Graves et al showed that TNF-α plays a central role in inflammatory 
reaction, alveolar bone resorption, and the loss of connective tissue 
attachment. He studied that IL-1β and TNF-alpha induce up regulation of 
adhesion molecules on leucocytes and endothelial cells, they stimulate the 
production of chemokines (which recruit circulating leucocytes to sites of 
inflammation) and they induce expression of other inflammatory mediators 
that potentiate inflammatory responses, such as the prostaglandins and 
MMPs.
35 
Cytokines up regulate the production of inflammatory mediators in the 
periodontium (e.g. prostaglandins, MMPs, cytokines, chemokines) leading to 
tissue destruction. Multiple feedback loops develop; for example, cytokines 
induce the secretion of prostaglandins, and increased prostaglandin 
concentrations result in increased cytokine secretion.
37 
Nakao et al demonstrated that IL-1β and TNF-a synergistically 
increase PGE2 and TNF-α was shown to upregulate PGE2 and COX 
production in HGFs via the JNK and NF-kB signaling pathways.
73
 





Palmqvist studied that there was a dose-dependent stimulation of IL-6 
and LIF mRNA and protein by IL-1b and TNF-alpha and dose-dependent 
stimulation of IL-11 mRNA and protein by IL-1b.
83 
In another study, Noguchi et al found that TNF-alpha, IL-1b and 
PGF2a all stimulated IL-6 production in cultured HGFs and PGF2a 
synergistically increased IL-6 production stimulated by TNF-alpha and IL-
1b.
78 
Yucel-Lindberg also found that TNF-alpha also induced IL-1a and IL-
1b production in HGFs and this was synergistically enhanced by the presence 
of bradykinin.
119 
Kent et al studied that IL-1b and TNF-alpha act synergistically in 
stimulating IL-6 secretion by HGFs and this combination of cytokines was 
shown to be many hundreds of times more potent in stimulating IL-6 
production than LPS.
52 
Kobayashi and Okada et al found that IL-1b and TNF-a induced IL-
1a secretion in HGFs and this production was differentially modulated by T-
cell derived cytokines including IFN-g and IL-4.
53 
Ohta et al studied that Chemokine expression is stimulated by 
cytokines; for example, IL-1b and TNF-alpha increase the production of 
RANTES/CCL5 in HGFs and IFN-ϒ, TNF-α and IL-4 cooperatively regulate 
CXCR3- agonistic chemokines in oral keratinocytes and fibroblasts.
81 





Liu et al studied enhanced accumulation of PMNLs has been reported 
in the gingival tissues of patients with periodontitis, and has been associated 
with up regulated IL-8, ICAM-1, IL-1b and TNF-alpha expression.
57 
Delima et al showed that inhibition of IL-1 using human soluble IL-1 
receptor type I (IL-1R) significantly reduced inflammation, connective tissue 
attachment loss, and bone resorption induced by periodontal pathogens.
21 
  In response to P. gingivalis oral gavage, Baker PJ et al studied that 
mice with genetically deleted IL-6 had decreased bone loss compared to wild-
type mice, suggesting that the production of IL-6, which is pro inflammatory, 
contributed to bone resorption.
8 
Garlet et al have demonstrated that similar cytokines considered 
harmful in the context of tissue destruction may play important roles in the 
control of periodontal infection.
31 
Dinarello et al found that TNF-α plays a critical role in both innate 
and adaptive immune responses, up-regulating antigen presentation and the 
bactericidal activity of phagocytes.
22 
Clements et al proposed that Tumor necrosis factor alpha is produced 
mainly by macrophages in response to agents such as lipopolysaccharide. The 
decrease in TNF-a seemed to reduce the host response, thereby leading to 
higher levels of bacteria; however, because the host response was less, there 





was a reduced expression of the cytokines that stimulate bone resorption, 
which resulted in net bone loss.
18 
Hosokawa et al studied that IL-4, IL-13 and IL-10 inhibited CXCL10 
production by IFN-g- or TNF alpha stimulated cells.
40 
Agnello et al showed that IL-4 is also supposed to attenuate 
periodontitis progression, in contrast to its putative destructive role, previously 
discussed. Similar to IL-10, IL-4 presents marked suppressive and anti-
inflammatory properties mediated by its capacity to inhibit the transcription of 
pro inflammatory cytokines and IFN-γ, then suppressing the polarization of 
Th1 cells.
2 
Jarnicki and Fallon et al found that IL-4 induces the production of 
cytokines with similar or complementary suppressive properties, such as IL-
10.
44 
Ihn et al 2002 studied that IL-4 is also able to inhibit the production of 
MMPs and RANKL and concomitantly induces the up-regulation of its 
respective inhibitors TIMPs and OPG reinforcing its potential protective role 
in PD pathogenesis.
41 
Immune Regulation in Periodontal Pathogenesis 
The importance of cytokines in the pathogenesis of periodontal disease 
is apparent at a number of levels. Not only do they act as initiators and 
regulators of innate and adaptive immunity but they also mediate the tissue 





damage, which leads to loss of function and clinical disease. Many of the non-
immune cell types of the periodontium (e.g. keratinocytes and fibroblasts) 
synthesize cytokines in response to bacteria and other cytokines, and cytokines 
also influence turnover of extracellular matrix components and the fibres of 
the periodontal ligament (PDL).
57 
Cytokines also have a central role in 
osteoclast activation. Cytokines drive the tissue destruction that results in the 
clinical manifestations of periodontitis through myriad overlapping effects on 
cells and mediators in the periodontium. The complex interactions between 
cytokines and immune responses make it difficult to distinguish and 
compartmentalize different aspects of the role of cytokines in driving tissue 
destruction. 
Numerous immune histochemical studies conducted have proposed the 
paradigm that periodontitis is a B cell lesion and the immunoregulatory role of 




 has characterized 3 subsets of T-helper cells based 
on their cytokine profile. Typical secretory products of Th1 cells are IL-2.IL-
12, TNFα and INFϒ and those of Th2 cells are IL-4, IL-5, IL-6,IL-10 and Th3 
are known to secret TGFβ.  
Mosman et al
69
 studied that Thl cytokines are involved in cell-
mediated inflammatory reactions. They increase the ability of macrophages to 
lull intracellular and extracellular pathogens and also mediate delayed type 
hypersensitivity reactions.  





  Reinhardt RA et al
94
 suggested that Th2 cytokines are found in 
association with strong antibody and allergic responses. These cells stimulate 
mast cells, eosinophils and immunoglobulin E (IgE) antibodies and are 
elevated in allergic diseases and helminth infections 
Ebersole & Taubman et al found that Cytokine profiles of cells 
extracted from 6 patients were consistent with Thl cells in that they were IL-2 
and IFN-ϒ positive but negative for IL-5.23  This study speculated that Thl 
cells may be destructive in periodontal disease via the production of IFN-ϒ by 
potential stimulation of macrophage secretion of IL-1 with subsequent bone 
resorption. However, the presence of messenger RNA for IFN-.I, IL-6 and IL-
13 but not for IL-2, IL-4 or IL-5 in CD4+ T cells extracted from periodontal 
disease lesions indicates that Tho cells may be involved in periodontal disease.   
Takeichi et al, showed that IFN-ϒ and IL-1-p messenger RNA was 
expressed by some gingival cells on extraction, indicating Type 1 cells and 
upon stimulation, IL-6 transcripts were also expressed but no IL-2 or IL-2 
receptor messenger RNA could be detected. These studies indicate that 
periodontal lesions are predominated by Th-1 cell types.
107
 
However other set of studies conducted by Yamazhki found that an 
increased percentage of IL-4-positive cells proportional with an increasing 
ratio of B cells to T cells.
116
 IL-4 was the prominent cytokine in periodontally 
affected tissues compared with IL-2, IFN-ϒ and IL-6. The demonstration of 
concentrations of IgG4 many times higher in sites of active periodontitis than 





in serum as well as significantly elevated concentrations compared with stable 
lesions also suggests a role for IL-4 and Th2 responses in periodontitis lesions. 
Analysis of IL-2: IL-4 ratios revealed significantly lower ratios for cells 
derived from periodontitis tissues compared with cells from gingivitis tissues. 
Taken together, these data seem to support the hypothesis that Thl cells are 
associated with the stable lesion, whereas a Th2 response may lead to 
nonprotective antibodies and disease progression. A Th2 response that results 




Karatzas et al showed that T-cell lines and clones specific for                       
P. gingivalis have been reported to resemble Tho cells, although one CD4-
positive clone did produce IL-4 and IL-5 messenger RNA, suggesting a Th2 
profile.
47 
Another study showed that P gingivalis-reactive T-cell lines derived 
from the peripheral blood of a P. gingivalis infected adult periodontitis and a 
gingivitis subject and from the gingival tissues of the adult periodontitis 
patient, contained both the Th2 cytokine, IL-4 and the Thl cytokines IFN-) I 
and IL-2, although there was a higher percentage of IL-4-positive T cells in 
the adult periodontitis-derived lines.
32
  
These data may therefore indicate that the full range of cytokine-
producing T cells (Tho, Thl and Th2) are all found in both gingivitis and 





periodontitis lesions, or may in fact offer supporting evidence for the concept 
that such distinction of T cells does not in reality exist. 
Effect of cytokines on vascular endothelium 
Cytokines have increased effect on endothelial cells. Circulating 
cytokines interact with specific receptors on various cell types and activate 
JAK-STAT, NFKB & smad signaling pathway leading to an inflammatory 
response involving cell adhesion, permeability & apoptosis. Cytokine induced 
activation of these pathways in endothelial cells modifies the 
production/activity of vasodilatory mediators like nitric oxide, prostacyclin, 
endothelium derived hyperpolarizing factor & bradykinin etc. 
When endothelial cells undergo inflammatory activation, an increase in 
expression of adhesion molecules such as selectins, vascular cell adhesion 
molecule -1 (VCAM-1) & intercellular adhesion molecule -1 (ICAM-1) 
promotes the adherence of the inflammatory cells monocytes, neutrophils, 
lymphocytes and macrophages and recruitment of additional cytokines growth 
factors and MMPs. The increased expression of these cell adhesion molecules 
are brought out by the release of cytokines like IL-1beta, IL-6, 8, TNF alpha 
etc during the inflammatory process. 
Cytokines could also induce vascular cell growth and migration.it was 
shown that TNF–α and IL-6 induce VGEF expression in cultured A431 human 
endothelial carcinoma and skeletal myoblast cell lines. 





Tumor necrosis factor a (TNF-a) and IL-1 mediate adhesion molecule 
expression on endothelial cells and hence play a role in the migration of 
polymorphonuclear neutrophils (PMNs), lymphocytes and macrophages (MQ) 
into the periodontal tissue. 
Dinarello CA et al showed that TNF-α acts in the cell migration 
process at multiple levels, inducing the up-regulation of adhesion molecules 
and the production of chemokines, which are chemotactic cytokines involved 
in cell migration to infected and inflamed sites.
22 
Springer  et al suggested that Many of the endothelial surface cell 
adhesion molecules, including Eselectin, VCAM- l and ICAM- l, are increased 
by inflammatory cytokines, such as TNF-a, IL-I.
104 
Bevilacqua MI et al suggested that both tumor necrosis factor αand 
IL-1 have been shown to act on endothelial cells to increase the attachment of 
polymorphonuclearneutrophils and monocytes and thus help to recruit these 
cells into sites of inflammation.
12 TNFα can initiate apoptosis. It can stimulate 
apoptosis in many cell types by the recruitment of the DED containing protein 
caspase-8 to the receptor complex following association of TRADD & FADD 
to TNRF-1. This receptor recruitment results in autocatalytic activation of 
caspase-8.it then initiates a hierarchical series of caspase activation steps 
culminating in the activation of effector caspase like caspase-3. Cytokines also 
promote adhesion of immune cells to EC and cause an increase in vascular 
permeability.  





M F Lademarco et al proposed that when TNF-alpha and IL-4 were 
combined, there was a synergistic increase in VCAM-1 expression and a 
dramatic prolongation of the appearance of VCAM-1 on the cell surface.
59 
This synergy results from a combination of transcriptional activation by TNF-
alpha and the stabilization of resulting transcripts by IL-4.  IL-4 allows sub 
threshold concentrations of TNF-alpha (concentrations that would not 
normally activate expression of adhesion molecules on the endothelium) to 
selectively increase VCAM-1 expression and to prolong its appearance on the 
surface of endothelial cells.59Interaction between vascular cell adhesion 
molecule-1 (VCAM-1) on endothelial cells and alpha 4 integrins on 
leukocytes is thought to mediate the selective recruitment of eosinophils and 
lymphocytes that occurs in allergic diseases. IL-4 is associated with allergic 
conditions and it has been shown to selectively increase expression of VCAM-
1 on endothelial cells in vivo, suggesting that it could be responsible for 
VCAM-1 expression in allergic disease. Using a combination of 
immunofluorescence, flow cytometry and Northern analysis, we compared the 
effect of TNF-alpha and IL-4 on VCAM-1 expression. 
Toi, M et al suggested that IL-4 has emerged as a potent mediator of 
endothelial cell function. It acts as an endothelial cell growth factor, 
specifically increases vascular cell adhesion molecule (VCAM)-1.
115 
M H Thornhill suggest that whereas IL-1 and TNF- alpha alone are 
unselective in terms of leukocyte adhesion to EC, the combination of TNF (or 





LT) with IL-4 or IFN-gamma may be of key importance in determining the 
recruitment of a lymphocyte-predominant infiltrate in immune mediated 
inflammation, and in initiating the transition from acute to chronic 
inflammation.
60 
Effect of cytokines on bone cells 
Graves DT et al suggested that inflammation and bone loss are 
hallmarks of periodontal disease.
37
 Accumulated evidence demonstrates that 
PD involves bacterially derived factors and antigens that stimulate a local 
inflammatory reaction and activation of the innate immune system. 
Proinflammatorymolecules and cytokine networks play essential roles in this 
process. Interleukin-1 and tumor necrosis factor-alpha seem to be primary 
molecules that, in turn, influence cells in the lesion. Eventually, a cascade of 
events leads to osteoclastogenesis and subsequent bone loss via the receptor 
activator of nuclear factor-kappa B (RANK)–RANK ligand (RANKL)–
osteoprotegerin (OPG) axis. The initial response to bacterial infection is a 
local inflammatory reaction that activates the innate immune system. 
Amplification of this initial localized response results in the release of an array 
of cytokines and other mediators and propagation of inflammation through the 
gingival tissues.  
The failure to encapsulate this „„inflammatory front‟‟ within gingival 
tissue results in expansion of the response adjacent to alveolar bone. Whether 
bone loss will occur in response to an inflammatory reaction is now known to 





depend on two critical factors. First, the concentration of inflammatory 
mediators present in gingival tissue must be sufficient to activate pathways 
leading to bone resorption.  
Lerner UH et al said that the inflammatory mediators must penetrate 
gingival tissue to reach within a critical distance to alveolar bone.
56
 Achieving 
critical concentrations of inflammatory mediators that lead to bone resorption 
depends on the expression of proinflammatory cytokines, such as interleukin 
(IL)-1, -6, -11, and -17, tumor necrosis factor-alpha (TNF-a), leukemia 
inhibitory factor and oncostatin M. This is the opposite of the expression of 
anti-inflammatory cytokines and other mediators, such as IL-4, -10, -12, -13, 
and -18, as well as interferon-beta (IFN-b) and -gamma (IFN-g), which serve 
to inhibit bone resorption.  
Assuma R et al demonstrated that in an animal model, 
Porphyromonasgingivalis (Pg)-soaked silk ligatures applied to posterior 
mandibular teeth to induce experimental periodontitis showed significant 
inflammatory cell recruitment and osteoclast formation surrounding bone in 
the control primates.
6
 Thus, infection with Pg in these animals was associated 
with expansion of the inflammatory front to alveolar bone. In contrast, 
antagonists to cytokines TNF-alpha and IL-1 reduced the appearance of 
inflammatory cells in this region and the formation of bone resorbing 
osteoclasts. Injection of these antagonists reduced recruitment of inflammatory 
cells by 80%, osteoclast formation by 67% and bone loss by 60% compared to 





control sites (P <0.01).
 
These findings suggested that inhibition of the 
inflammatory mediators can prevent the inflammatory front from reaching 
alveolar bone, and it was associated with a reduction in bone loss in this 
animal model.   
 
Fig 2-Stimulation and inhibition of osteoclast formation and bone resorption 
involves the interplay between a number of inflammatory cytokines and other 
mediators acting through RANKL binding to RANK on osteoclast progenitor 
cells. LIF = leukemia inhibitory factor; OSM = oncostatin M. Reprinted with 
permission from the International and American Associations for Dental 
Research. 
Nakashima T et al  proposed that During an inflammatory response, 
proinflammatorcytokines, such as IL-1b, -6, -11 and -17 and TNF-a, can 
induce osteoclastogenesis by increasing he expression of RANKL while 
decreasing OPG production in osteoblasts/stromal cells.
74 
Whereas anti-





inflammatory mediators, such as IL-13 and IFN-g, may lower RANKL 
expression and/or increase OPG expression to inhibit osteoclastogenesis.  
Mundy et al studied that Tumor necrosis factor molecules stimulate 
bone resorption by inducing the proliferation and differentiation of osteoclast 
progenitors and activating formed osteoclasts indirectly.
70 
It is now well 
accepted that a large consortia of cytokines, cell-signaling molecules and 
matrix metalloproteinases are dysregulated and intimately involved in the 
pathogenesis of periodontitis. The task ahead of us is to identify the various 
roles of these important biological mediators of inflammation and how to 
control them. A principal feature of inflammatory-mediated bone loss in 
periodontitis is enhanced osteoclast activity without a corresponding increase 
in bone formation. Osteoclasts are multinucleated cells that are derived from 
the monocyte ⁄ macrophage lineage and are considered to be the principal cell 
responsible for bone resorption (Boyle WJ et al).
15
 
Pettit AR et al said that multinucleated osteoclasts have been shown 
to resorb alveolar bone in both animal and human studies of periodontitis.
91 
The formation of osteoclasts is driven by cytokines present in the inflamed 
periodontal tissues, and understanding this process is central in the 
development of strategies to control this process.  
 
 





EFFECT OF CYTOKINES ON SOFT TISSUE 
Reynolds JJ et al found that the effects of cytokines and cell-signaling 
molecules on normal and pathological cellular process are important and it is 
proposed that their roles in the pathophysiology of extracellular matrix 
destruction result from their excessive production, dysregulation or inadequate 
inhibition of these cytokines.
95 
Le J et al suggested that tumor necrosis factor is also a multipotential 
cytokine having a wide variety of biological effects and has been suggested to 
have similar effects as IL- 1.
55 
Clemens M J et al found that tumor necrosis factor alpha is produced 
mainly by macrophages in response to agents such as lipopolysaccharide. IL-1 
and tumor necrosis factor a are key mediators of chronic inflammatory 
diseases and have the potential to initiate tissue destruction and bone loss in 
periodontal disease IL-1 has been shown to stimulate fibroblasts in culture to 
produce collagenase.
18 
Meikle MC, et al
64
 found that tumor necrosis factor also mediates 
tissue destruction by stimulating collagenase and degradation of type 1 
collagen by fibroblasts leading to connective tissue destruction. Cytokines 
drive the secretion of inflammatory mediators and destructive enzymes 
Noguchi et al studied in 2007 that Cytokines upregulate the production of 
inflammatory mediators in the periodontium (e.g. prostaglandins, MMPs, 





cytokines, chemokines) leading to tissue destruction. Multiple feedback loops 
develop; for example, cytokines induce the secretion of prostaglandins and 
increased prostaglandin concentrations result in increased cytokine secretion 





 in 2001 found that IL-1b and TNF-a 
induce COX-2 in oral epithelial cells and IL-1b upregulates COX-2 expression 
in HGFs. 
Yucel-Lindberg et al in 1999 found that IL-1b and TNF-a 
synergistically increase PGE2 production in HGFs and TNF-a was shown to 
upregulate PGE2 and COX production in HGFs via the JNK and NF-kB 
signaling pathways.
118 
Agarwal et al in 1995, identified that cytokines induce the secretion of 
other cytokines. IL-1b induces the expression of IL-6, IL-8 and TNF-a in 
HGFs, and also acts in an autocrine manner to induce further IL-1b 
expression. 
Palmqvist et al in 2008 conducted a study of cytokine expression in 
HGFs obtained from non-inflamed gingiva where there was a dose-dependent 
stimulation of IL-6 and LIF mRNA and protein by IL-1b and TNF-a and dose-
dependent stimulation of IL-11 mRNA and protein by IL-1b. In another study, 
TNF-a, IL-1b and PGF2a all stimulated IL-6 production in cultured HGFs and 
PGF2a synergistically increased IL-6 production stimulated by TNF-a and IL-







 TNF-alpha also induced IL-1a and IL-1b production in HGFs, and this 
was synergistically enhanced by the presence of bradykinin. It was observed 
that the up regulation of IL-6 production by HGFs that is induced by IL-1b is 
mediated by the p38 MAPK and NFkB signalling pathways. IL-1b and TNF-a 
act synergistically in stimulating IL-6 secretion by HGFs and this combination 
of cytokines was shown to be many hundreds of times more potent in 
stimulating IL-6 production than LPS.  
Cytokine effect on epithelium 
Bacteria by up regulate cytokine secretion and expressing adhesion 
molecules. Keratinocytes when challenged with bacterial infection, express a 
large variety of cytokines like IL-1α, IL-1β, IL-8 and TNF-α etc. 
Physiologically keratinocytes have high turnover rate. 
Cytokine effect on gingival fibroblast 
The gingival fibroblast and periodontal ligament cells are involved in 
release of various cytokines which not only function of inflammatory cells but 
also remodeling of gingiva, periodontal ligament and alveolar bone. An 
additional illustration of the important role of gingival fibroblasts in PD 




 said that during inflammation, resident GF are 
triggered by cytokines released by macrophages to enhance their synthesis of 





cytokines. Thus, IL-1β and TNF-α stimulate the expression and release of IL-6 
and IL-11 in human gingival fibroblast. HGFs are responsive to LPS and 
constitutively express mRNA for a variety of TLRs and NLRs, stimulation of 
which leads to production of pro-inflammatory cytokines such as IL-6, IL-8. 
HGFs challenged with P. gingivalis and E. coli LPS secrete IL-6 and IL-8 with 
no evidence of LPS tolerance, indicating that HGFs can sustain the 
inflammatory response in the periodontium.  
In addition to LPS, HGFs also respond to outermembrane protein and 
polysaccharide of P. gingivalis by producing inflammatory cytokines. It was 
also found that primary HGFs and PDL fibroblasts respond to P. gingivalis by 
increasing gene expression for IL-1b, IL-6, IL-8, TNF-a and regulated on 
activation normal T-cell expressed and secreted (RANTES), with 
heterogeneity in responsiveness between fibroblasts from different donors and 
this may be important in determining susceptibility to periodontitis.  
Elevated levels of cytokines can also locally amplify responses to LPS. 
For example, CD141 HGFs those were primed with IFN-gamma increased 




 reported increased serum levels of IL-1b, TNF, OC, 
soluble intercellular adhesion molecule (sICAM), IL-6, MMP-9 have been 
reported in experimental studies in animal models as well as in clinical studies 
in humans mediated by metalloproteinases.  





Biomarkers in periodontal diagnosis 
Traditional clinical assessment of periodontal diseases such as pocket 
probing depth, Clinical attachment level, bleeding on probing etc., though 
provide information on past periodontal progression ,are  error prone methods 
which makes it difficult for the clinicians to determine the  current and future 
clinical progression of the diseases 
A systematic review by Buduneli N
16
 suggested that host-derived 
diagnostics are at an early stage of development. Analysis of the cytokine 
levels in serum, saliva, GCF etc are considered to be a good diagnostic marker 
as they help in assessing the progression of the disease and helps in a better 
evaluation of therapeutic prognosis.  
Cytokines in gingival tissues and cell culture supernatants 
Yin L, et al found that the relative amount of IL-1 beta mRNA 
expression of gingival samples from patients with adult periodontitis was 
much higher than that from the normal control. The relative amount of TNF-
alpha mRNA expression, gingival samples from AP patients was also much 
higher than that from the normal control.
121 
  K. Fujihashi et al conducted a study on gingival mononuclear cells 
and showed that GMC from localized inflammatory tissues in severe stages of 
AP possess a distinct cytokine profile represented by high levels of IL-5 and 





IL-6 mRNA expression and protein synthesis, whereas IL-2 and IL-4 were not 
detected.
45 
Tervahartiala et al found that Aggressive periodontitis gingival tissue 
has an elevated expression of TNF-alpha and especially its p55 receptor, 
suggesting that TNF-alpha may contribute to tissue degradation in 
periodontitis.
109 
To elucidate the mechanisms of tissue breakdown in periodontitis, 
Kamagata Y et al
46
  examined cytokine production by human periodontitis 
gingival tissue. Twelve periodontitis patients were included in this study. 
Control subjects with healthy periodontium consisted of nine individuals. 
Gingival samples were biopsied from inflamed or healthy gingival tissues. 
Biopsy specimens were dissected into fragments 3 mm in diameter and plated 
onto 24 well culture plates with RPMI 1640 medium. IL-1 activity was 
measured by a growth inhibition assay using melanoma cell line A 375. An 
enzyme-linked immunosorbent assay (ELISA) was used for measuring levels 
of human IL-1 alpha, IL-1 beta. TNF alpha activity was measured by a growth 
inhibition assay using cell line LM2D6. IL-1 activity was detected in 
significantly (p less than 0.001) higher levels in culture supernatants from 
gingival tissues in periodontitis (48.0 +/- 23.3 units/ml) than in control tissues 
(2.3 +/- 0.6 units/ml), however, levels of IL-1 activity were not associated with 
periodontal pocket depth or extent of alveolar bone resorption in periodontitis. 
Cytokines in serum. 





Hence, it has been proposed by Beck and Offenbacher et al
11
 that 
patients with periodontitis may have elevated circulating levels of some 
inflammatory markers. Monocytes, macrophages and other cells (including 
fibroblasts and endothelial cells) respond to the dental plaque microorganisms, 
membrane associated vesicles, lipopolysaccharides (LPS) and other soluble 
and particular fractions by secreting a number of chemokines and 
inflammatory cytokines, especially tumor necrosis factor (TNF)-α, 
prostaglandin (PGE2), interleukins (IL-1β and IL-6). These inflammatory 
cytokines and prostaglandin have been associated with the presence of various 
bacterial infections including periodontitis.  
Górska et al assessed the relationship between clinical parameters and 
concentrations of the key cytokines (IL-1β, TNF-α, IL-2, IFN-γ, IL-4, IL-10), 
important in the initiation and progression of periodontal disease, within 
inflamed gingival tissues and serum samples from patients with severe chronic 
periodontitis. The concentrations of IL-1β, TNF-α, IL-2, IFN-γ were, on 
average, significantly higher in serum samples and gingival tissue biopsies 
from periodontitis patients than in healthy controls. However, serum samples 
from both groups showed high individual variability of cytokine profiles, and 
no association between cytokine concentrations and clinical parameters of 
periodontitis was found. On the contrary, IL-4 and IL-10 levels in both kinds 
of samples obtained from patients and controls were generally low or even 
undetectable and remained, on average, on the same level. These results 





indicate that high variability of cytokine concentrations and low frequency of 
their detection in serum samples from periodontitis patients make these 
determinations useless for the detection of disease presence and/or its 
severity.
34 
Cytokine levels in GCF 
Hence researches were conducted in the direction where oral fluids 
were analyzed as diagnostic medium for biomarker evaluation. Gingival 
crevice fluid (GCF) is a complex mixture of substances derived from serum, 
leukocytes and structural cells of the periodontium and oral bacteria. These 
substances possess a great potential for serving as indicators of periodontal 
disease and healing after therapy. The host-derived substances in GCF include 
antibodies, cytokines, enzymes and tissue degradation products. The 
antibodies in gingival crevicular fluid are comprised of both locally and 
systemically synthesized molecules and they reflect periodontal colonization 
by particular microbial species. They may also be crucial in eliciting 
destructive inflammatory reactions in the periodontium. 
Beck et al
10
 studied that Low GCF levels of monocytic products such 
as interleukin-1 or tumor necrosis factor are detected in gingivitis which 
indicated a low activation level of cells associated with chronic inflammation.  







 found that levels of GCF interleukin-1 were 
increased in samples from periodontitis patients, regardless of the severity of 
disease at the sample site.  
  Catherine Giannopoulou et al
17
 found that in periodontally diseased 
subjects the total amounts of IL-1β, IL-6 and IL-8 were significantly elevated 
as compared to healthy subjects, whereas IL-4 showed an inverse relationship 
to periodontal status and higher amounts were found in the healthy group. The 
amounts of all four cytokines were positively correlated with probing depths. 
IL-4, IL-6 and IL-8 were significantly correlated to smoking while stress was 
associated with IL-1β, IL-6 and IL-8 levels. Hence they concluded that 
crevicular IL-1β, IL-6 and IL-8 reflect the activity of periodontal destruction, 
whereas IL-4 shows an inverse correlation to it. The enhanced production of 
inflammatory cytokines in the presence of smoking and stress may have 
clinical consequences.  
Saliva as diagnostic medium 
Recent reviews have reported presence of several mediators of chronic 
inflammation and tissue destruction in whole saliva of periodontitis patients.
48
 
S. Chiappin et al
98
 said that Salivary glands have rich vasculature 
from which saliva is filtered and processed. Salivary components may 
originate entirely from the salivary glands or may be derived from the blood 
by passive diffusion or active transport. In cases where components in saliva 





are derived from the blood, levels of biochemical and immunological 
components measured in saliva may reflect blood levels. Substitution of saliva 
samples for blood in analysis of biomarkers is of considerable interest because 
collection of saliva is less invasive and does not have any of the risks 
associated with collection of blood. While there is some information about 
single biomarkers in saliva (such as cortisol), the correspondence to blood 
levels varies widely by biomarker and to date there has been little published 
regarding how well blood levels of specific cytokines or other biomarkers are 
represented in saliva, or how saliva collection technique affects recovery of 
specific bio-markers.  
Whole saliva represents pooled samples with contribution from all 
periodontal sites and thus helps to provide an overall assessment of diseases 
status.
65 
Saliva can be collected with or without stimulation. Stimulated saliva 
is collected by masticatory action (i.e., from a subject chewing on paraffin) or 
by gustatory stimulation (i.e., application of citric acid on the subject's tongue; 
Mandel, 1993).
63
 Stimulation obviously affects the quantity of saliva; 
however, the concentrations of some constituents and the pH of the fluid are 
also affected. Unstimulated saliva is collected without exogenous gustatory, 
masticatory, or mechanical stimulation. Unstimulated whole saliva often 
correlates to systemic clinical conditions more accurately than stimulated 
saliva, since materials use to stimulate flow may change salivary composition 







 suggested that the best two ways to collect whole 
saliva are the draining method, in which saliva is allowed to drip off the lower 




 in the year 2009 conducted a study to analysis  the 
levels of IL-1,1L-6, & TNF alpha in saliva of 84 chronic periodontitis patients 
and 81 controls. There was no statistical difference in the level of IL-6 & TNF 
alpha.it was therefore stated that IL-1 alone can differentiate periodontitis.  
kaufman E  et al
49
 suggested that Saliva is of additional advantage as 
it acts as a noninvasive  diagnosis fluid to measure biomarkers released during 
disease initiation and progression.  
Miller et al
65
 suggested that The localized nature and  proximity of 
periodontal lessions to the oral cavity, ready availability & ease in collection 
rewards saliva with additional credits for saliva to be used as a natural 
biological fluid for measurement of microbial and protein biomarkers of the 
disease process. Furthermore, Frodge et al evaluated salivary concentrations 
of TNF-a, RANKL, and ICTP in 35 subjects with moderate to severe chronic 
periodontitis in comparison with 39 healthy controls. The authors reported that 
salivary TNF alpha levels were significantly elevated in chronic periodontitis 
patients suggesting the utility of this biomarker in a panel of salivary 
parameters that could facilitate the screening, diagnosis and management of 
periodontal disease.  





Analysis of saliva for Systemic inflammatory response in periodontal 
disease 
Chronic periodontal infections are associated with systemic changes to 
blood and blood forming organs. Periodontal disease is capable of 
predisposing to vascular disease given the abundance of gram negative species 
involved, easily detectable levels of pro inflammatory cytokines, dense 
immune cell infiltrate involved, association of peripheral fibrinogen and white 
cell count, extent and chronicity of disease. 
Periodontitis can elicit a systemic inflammatory response by activating 
the hepatic acute phase response. This occurs presumable as a consequence of 
systemic appearance of transient and recurrent bacteremia of oral origin, 
which has been a long recognized characteristic of periodontal infections.  
Offenbacher S et al
80
 hypothesized that gram negative anaerobe 
pathogens from periodontium trigger release of biologically active mediators 
such as PGE2, and TNFα in circulation causing premature labor.   
Cross sectional evidence indicates that periodontitis elicits a mild 
elevation in markers of acute phase response including C reactive protein, 
haptoglobin, alpha 1 antitrypsin, and fibrinogen. The liver in response to 
systemic challenge of organisms secretes acute phase proteins. This acute 
phase response is triggered by blood borne oral LPS and oral bacteria which 
elicit release of cytokines IL-6, TNF α. Markers of acute phase response 





associated with periodontitis and cardiovascular risk include C reactive 
protein, increase in WBC count and increase in α1 anti-trypsin, haptoglobin 
and fibrinogen and decrease in albumin.  
Noack B et al
77
 determined that CRP plasma levels are increased in 
periodontitis. Also, there are elevated levels of CRP associated with infection 
with subgingival organisms often associated with periodontal disease, 
including Porphromonasgingivalis, PrevotellaIntermedia, Campylobacter 
rectus, Bacteriodesforsythus.   
Havemose-Poulsen A et al
35
 reported an increase in the 
proinflammatory cytokines including IL-1α, IL-1β, IL-RA, IL-6, IL-10, TNF α 
levels in systemic circulation following periodontal disease 
Floriano PN et al
28
 stated that CRP remains a non-specific 
inflammatory response factor that increases in many conditions including 
periodontal diseases.  
However, whole saliva is most frequently studied when salivary 
analysis is used for the evaluation of systemic disorders. Whole saliva (mixed 
saliva) is a mixture of oral fluids and includes secretions from both the major 
and minor salivary glands, in addition to several constituents of non-salivary 
origin, such as gingival crevicular fluid (GCF), expectorated bronchial and 
nasal secretions, serum and blood derivatives from oral wounds, bacteria and 





bacterial products, viruses and fungi, desquamated epithelial cells, other 
cellular components, and food debris. 
Floriano et al
29
 reported that a group of salivary biomarkers can 
complement findings of an electrocardiogram (ECG) following an acute 
myocardial infarction. These markers include CRP, myoglobin and 
myeloperoxidase, in combination with an ECG, showed a highly significant 
correlation with myocardial infarct patients as compared to healthy controls. 
The clinical value of salivary proteomic biomarkers in periodontal disease 
diagnosis is under experimental development and is based on profile changes 
in molecules involved in inflammation, collagen degradation and bone loss. 
Tatjana Todorovic et al
114
 in  2006 examined the activity of CK, 
LDH, AST, ALT, GGT, ALP and ACP in saliva from patients with 
periodontal disease before and after periodontal treatment and in saliva from 
healthy patients .Patients with periodontal disease were under conventional 
periodontal treatment. There was statistically significant increase of activity of 
CK, LDH, AST, ALT, GGT, ALP, ACP in saliva from patients with 
periodontal disease in relation to control group and also a positive correlation 
between the activity of examined salivary enzymes and value of the gingival 
index. After conventional periodontal therapy the activity of all salivary 
enzymes was significantly decreased. He concluded that activity of these 
enzymes in saliva, as biochemical markers for periodontal tissue damage, may 





be useful in diagnosis, prognosis and evaluation of therapy effects in 
periodontal disease.   
Balwant Rai et al
93 
estimated salivary tumor necrosis factor alpha 
levels in periodontitis and healthy normal. Significantly higher levels Salivary 
tumor necrosis factor alpha of was observed in periodontitis patients as 
compared to controls (p<0.001). He concluded that Saliva provides an ideal 
medium for the detection of proinflammatory markers of the oral cavity. 
Salivary TNF-alpha analysis may be a useful diagnostic tool and a potential 
prognostic marker in periodontal disease.   
Patricia Yen Bee Ng 2007
90
 evaluated the association between 
radiographic evidence of alveolar bone loss and the concentration of host-
derived bone resorptive factors (interleukin-1 beta, tumor necrosis factor-
alpha, interleukin-6, prostaglandin-E2) and markers of bone turnover 
[pyridinolinecrosslinkedcarboxyterminaltelopeptide of type I collagen (ICTP), 
osteocalcin, osteonectin] in stimulated cells.  
Saliva has been proposed as a noninvasive diagnostic fluid that could 
be used in the diagnosis of oral and systemic diseases. The levels of salivary 
biomarkers, such as cytokines, could potentially be used as a surrogate to 
distinguish periodontally healthy individuals from subjects with periodontitis. 
 
 





Drawbacks of salivary analysis 
  Various authors like Zhang et al suggested that In spite of this 
progress, some of the biomarkers identified are not disease specific.
120 
Therefore, R. P. Teles investigated the levels of 10 different cytokines in 
saliva between a group of periodontally healthy individuals and a group of 
subjects with periodontitis. Correlations between the concentrations of these 
10 cytokines and clinical parameters of periodontal disease were also 
examined. They found that mean salivary levels of granulocyte–macrophage 
colony-stimulating factor, interleukin-1β, interleukin-2, interleukin-4, 
interleukin-5, interleukin-6, interleukin-8, interleukin-10, interferon-γ and 
tumor necrosis factor-α could not discriminate between periodontal health and 
disease.
108 
Future trends in salivary bio markers. 
However, Diagnostic methods used in clinical practice today lack the 
ability to detect the onset of inflammation and to identify those patients who 
are susceptibity to future disease progression. oral fluid based  point of care 
(POC) diagnostics are commonly used in medicine and, more recently, is 
being adapted for the potential “ chair side “ determination of oral diseases. 
The latest clinical applications use new “lab-on-a-chip” (LOC) technologies as 
rapid POC diagnostic test for systemic infectious diseases and periodontal 
disease. The development of rapid Point of Care chair side diagnostics has the 





potential for the early detection of periodontal infection and progression to 
identify the incipient disease.   
Amy et al
4
 developed a portable microfluidic device for detection of 
potential biomarkers of periodontal disease in saliva.
4
 The device performs 
rapid microfluidic chip-based immunoassays (<3–10 min) with low sample 
volume requirements (10 μL) and appreciable sensitivity (nM–pM). This 
method facilitates hands-free saliva analysis by integrating sample 
pretreatment (filtering, enrichment, mixing) with electrophoretic 
immunoassays to quickly measure analyte concentrations in minimally 
pretreated saliva samples. The microfluidic chip has been integrated with 
miniaturized electronics, optical elements, such as diode lasers, fluid-handling 
components and data acquisition software to develop a portable, self-contained 
device. The device and methods are being tested by detecting potential 
biomarkers in saliva samples from patients diagnosed with periodontal 
disease. The microchip-based analysis can readily be extended to detection of 
biomarkers of other diseases, both oral and systemic, in saliva and other oral 
fluids. 





MATERIALS AND METHODS 
30 patients who attended the outpatient Department of periodontology, 
Ragas Dental College and Hospitals, Chennai were enrolled in the study. 
Patients were divided into two groups based on their periodontal health status 
as group A and B. Informed consent was obtained from all the patients. The 
patients were informed that this research work was in no way directly related 
to the therapy or cure of the disease. The study was undertaken following 
approval from the institutional review board. 
Selection criteria 
Group A: Periodontaly healthy group included 15 subjects of age 
between 25- 50 exhibiting no signs of periodontal disease, determined by 
clinical attachment loss <2mm, absence of bleeding on probing and PPD 
<3mm. 
Group B: Periodontitis group included 15pateints of age between 25-
55 with more than 6 sites exhibiting PPD ≥ 5 mm, CAL ≥ 3mm and 
radiographic evidence of bone loss. 
Exclusion criteria included 
 Patients with history of periodontal therapy or antibiotic therapy in the 
past 6 months  





 Patients with history of systemic diseases that may affect the 
periodontal status 
 Pregnancy and Lactation 
 Smokers 
 Evidence of any other active oral infections eg: pulpal pathology. 
Clinical evaluation:- 
 Clinical evaluation was done using mouth mirror and William’s 
periodontal probe. The probing depth, clinical attachment loss, bleeding on 
probing and plaque index was evaluated.  
Serum collection: 
3 ml of Peripheral blood drawn from patients using venepuncture from 
the antecubital fossa to be used for ELISA analysis. 
Peripheral blood was drawn prior to onset of Phase I periodontal 
therapy in periodontitis patients. All patients underwent a complete physical 
examination and hematological investigation in Ragas General Hospital to rule 
out any systemic diseases. 
Saliva collection:- 
Salivary collection is done according to the technique by Navazesh et 
al 2008.
75
 The patients were advised to refrain from intake of any food or 
beverage (water exempted) for one hour before sampling. The subjects were 





advised to rinse his or her mouth several times with distilled water and then to 
relax for five minutes. The patient is asked to lean the head forward over the 
container with the mouth slightly open and allow the saliva to drain into the 
container with the eyes open. The time lasted for saliva collection is five 
minutes, the saliva is collected in a sterile disposable plastic container and the 




 Test Tubes 
Centrifuge Tubes 
 Laboratory Centrifuge 
Refridgerator 
autoclavable containers for saliva collection 
Ice pack (for transfer) 
Microtitre plate reader fitted with appropriate filters (450nm required with 
optional 620nm reference filter) 





Microplate washer or wash bottle 10, 50, 100, 200 and 1,000μl 
adjustable single channel micropipettes with disposable tips 50-300ml multi-
channel micropipette with disposable tips 
Multichannel micropipette reagent reservoirs 
Distilled water 
Vortex mixer 
Miscellaneous laboratory plastic and/or glass 
Principle of the method 
The Diaclone ELISA kit used in the study is a solid phase sandwich 
ELISA for the in-vitro qualitative and quantitative determination of proteins in 
oral or biological fluid. A capture Antibody highly specific for the protein to 
be detected has been coated to the wells of the microtitre strip plate provided 
during manufacture. Binding of protein samples and known standards to the 
capture antibodies and subsequent binding of the biotinylated a secondary 
antibody to the analyte is completed during the incubation period. Any excess 
unbound analyte and secondary antibody is removed. The HRP conjugate 
solution is then added to every well including the zero wells, following 
incubation. Excess conjugate is removed by careful washing. A chromogen 
substrate is added to the wells resulting in the progressive development of a 
blue coloured complex with the conjugate. The colour development is then 
stopped by the addition of acid turning the resultant final product yellow. The 





intensity of the produced coloured complex is directly proportional to the 
concentration of the protein present in the samples and standards. The 
absorbance of the colour complex is then measured and the generated OD 
values for each standard are plotted against expected concentration forming a 
standard curve. This standard curve can then be used to accurately determine 
the concentration of protein in the sample tested. 
Ellisa kit contents:- 
TNF alpha kit included  96 well microtitre strip plate, Plastic plate 
covers, Standard  (800pg/ml), Standard Diluent (Human serum), Control, 
Biotinylated anti-TNF alpha, Biotinylated Antibody diluent, Streptavidin-
HRP, HRP Diluent, Wash Buffer, TMB Substrate, Stop reagent. 
IL-4 kit content included 96 well microtitre strip plate, Plastic plate 
covers, Standard  (35pg/ml), Standard Diluent (Human serum), Control, 
Biotinylated anti-IL-4, Biotinylated Antibody diluent, Streptavidin-HRP, HRP 
Diluent, Wash Buffer, TMB Substrate, Stop reagent. 
ASSAY preparation for TNF alpha 
The number of microwell strips required to test the desired number of 
samples and appropriate number of wells needed for running zeros and 
standards were determined and the wash buffer and standard diluent buffer for 
TNF alpha were prepared according to the instruction given by the 
manufacturer.  





Preparation of the standard for TNF alpha- 
Standard vials must be reconstituted with the volume of standard 
diluent shown on the vial immediately prior to use. This reconstitution gives a 
stock solution of 800pg/ml of TNF alpha and it is mixed gently by repeated 
aspiration /ejection. Serial dilutions of the standard are made directly in the 
assay plate to provide the concentration range from 800 to 25pg/ml. A fresh 
standard curve is produced for each new assay. Immediately after 
reconstitution 200ml of the reconstituted standard is added to well’s A1 and 
A2, which provides the highest concentration standard at 800pg/ml. 100ml of 
appropriate standard diluent is added to the remaining standard wells B1 and 
B2 to F1 and F2. 100ml from wells A1 and A2 is transfered to B1 and B2. The 
well contents are mixed by repeated aspirations and ejections taking care not 
to scratch the inner surface of the wells. 1:1 dilution wascontinued using 
100ml from wells B1 and B2 through to wells F1 and F2 providing a serial 
diluted standard curve ranging from 800pg/ml to 25pg/ml. 100ml from the 
final wells of the standard curve (F1 and F2) are discarded.  
Preparation of controls for TNF alpha 
Freeze-dried control vials are reconstituted with the most appropriate 
Standard Diluent to the samples. The supplied Controls are also reconstituted 
with the volume of Standard Diluent indicated on the vial. Reconstitution of 
the freeze-dried material with the indicated volume, gives a solution at the 
concentration as was stated on the vial. 





Biotinylated anti-TNF alpha is prepared by dilutingbiotinylated anti- 
TNF alpha with biotinylated antibody diluent. 5 µl of steptavidin is mixed 
with 0.5 ml of HRP diluent immediately before use. Further the HRP solution 
to volumes appropriate for the required number of wells is diluted in a clean 
glass vial. 
ELISSA test for TNF alpha was carried as mentioned below. 
ASSAY STEP                                           DETAILS 
1. Addition Standard curve was prepared as mentioned above 
2. Addition 
100ml of each, Sample, Standard, Control and 
zero (appropriate standard diluent)was added in 
duplicate to appropriate number of wells 
3. Addition 
50ml of diluted biotinylated anti-TNFalpha was 
added to all wells 
4. Incubation 
the plate is covered with a plastic plate cover and 
incubated at room temperature (18 to 25°C) for 3 
hour(s) 
5. Wash 
Plate was washed as as follows: 
a) The liquid from each well is aspirated 
b) 0.3 ml of 1x washing solution was dispensed  
into each well 
c) The contents of each well were aspirated again. 
d)  step b and c were repeated another two times 
6. Addition 
100μl of Streptavidin-HRP solution were added 
into all wells 
7. Incubation 
The  plate was again coveedr and incubate at 
room temperature (18 to 25°C) for 30 min 
8. Wash Wash step5 was repeated again. 
9. Addition 
100μl of ready-to-use TMB Substrate Solution 
was added into all wells 
10. Incubation 
The plates were covered with aluminum cover 
and then incubated in the dark for 12-15 minutes 
at room temperature. . 
11. Addition 
100μl of H2SO4:Stop Reagent was added  into all 
wells 





H2SO4: Stop Reagent is added in the end of the incubation and the 
readings are measured by an spectrophometer using 450nm as the primary 
wave length and 620nm as the reference wave length. 
ASSAY preparation for IL-4 
The number of microwell strips required to test the desired number of 
samples plus appropriate number of wells needed for running zeros and 
standards were determined and the wash buffer and standard diluent buffer for 
IL-4 were prepared according to the instruction by the manufacturer. 
Preparation of the standard for IL-4 
Standard vials were reconstituted with the volume of standard diluent 
shown on the vial immediately prior to use. This reconstitution gives a stock 
solution of 35pg/ml of IL-4 and it is mixed gently by repeated aspiration 
/ejection. Serial dilutions of the standard were made directly in the assay plate 
to provide the concentration range from 35 to 1pg/ml. A fresh standard curve 
is produced for each new assay.  Immediately after reconstitution 200µl of the 
reconstituted standard is added to well’s A1 and A2, which provides the 
highest concentration standard at 35pg/ml. 100µl of appropriate standard 
diluent is added to the remaining standard wells B1 and B2 to F1 and F2.  
100µl from wells A1 and A2 to B1 and B2 is transferred. The well contents 
are mixed by repeated aspirations and ejections taking care not to scratch the 
inner surface of the wells.  1:1 dilution was continued using 100µl from wells 





B1 and B2 through to wells F1 and F2 providing a serial diluted standard 
curve ranging from 35pg/ml to 1pg/ml.  100µl from the final wells of the 
standard curve (F1 and F2) were discarded. 
Preparation of controls for IL-4 
Freeze-dried control vials were reconstituted with the most appropriate 
Standard Diluent to the samples. The supplied Controls are also reconstituted 
with the volume of Standard Diluent indicated on the vial. Reconstitution of 
the freeze-dried material with the indicated volume, gave a solution at the 
concentration as was stated on the vial. 
Biotinylated anti-IL-4 was prepared by diluting biotinylated anti- IL-4 
with biotinylated antibody diluent. 5 µl of streptavidin was mixed with 0.5 ml 
of HRP diluent immediately before use. Further the HRP solution to volumes 












Method for IL-4 assay 
ASSAY STEPS                                                                                               
1 Addition Standard curve is prepared as mentioned above 
2 Addition 
100µl of each sample and zero is added into 
duplicate to appropriate number of wells 
3 Incubation 
The plates are covered with plastic cover and 
incubated at room temperature (18 to 25°c) for 2 
hours 
4 Wash 
Plate was washed as  as follows: 
a) The liquid from each well is aspirated 
b)  0.3 ml of 1x washing solution was dispensed  into 
each well 
c)  The contents of each well were aspirated again. 
d)  step b and c were repeated another two times 
5 Addition 
50µl of diluted biotinylated anti-IL-4 was added to 
all wells 
6 Incubation 
The plates are covered with plastic cover and 
incubated at room temperature (18 to 25°c) for 1 
hour. 
7 Wash Step5 was repeated. 
8 Addition 
100µl of streptavidin –HRP solution is added into all 
wells. 
9 Incubation 
The plates are covered with plastic cover and 
incubated at room temperature (18 to 25°c) for  
30min. 
10 Wash Wash step 5 is repeated again 
11 Addition 
100μl of ready-to-use TMB Substrate Solution was 
added into all wells 
12 Incubation 
The plates were covered with aluminum cover and  
then incubated in the dark for 12-15 minutes at room 
temperature 
13 Addition 
100μl of H2SO4:Stop Reagent was added  into all 
wells 
 
  H2SO4: Stop Reagent is added in the end of the incubation and the 
readings are measured by a spectrophometer using 450nm as the primary wave 
length and 620nm as the reference wave length. 





Measurement of High Sensitivity C - reactive protein (hs-CRP):- 
Measurement of hs-CRP was performed using a immunoturbidimetric 
assay performed on a dirui cs-400 auto analyser. The assay range was 1.45-
6.80 mg/l. 
Statistical analysis: 
The circulatory and salivary levels of TNF alpha and IL-4 in 
periodontal health and disease was compared by calculating the mean and 
standard deviation for each group. Sample student T test was used for 
statistical analysis and P value was calculated. Correlation coefficient of 
serum, saliva levels of TNF alpha, IL-4 and salivary hs-CRP in periodontal 
health and disease was analyzed using Pearson’s correlation.  
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A.HARD TISSUE EXAMINATION: 
 
 
B.SOFT TISSUE EXAMINTAION: 







































____________ aged about _____ years Hindu/Christian/Muslim/ 
____________ residing at ______________________________________do 
hereby solemnly and state as follows.  
 I am the deponent herein; as such I am aware of the facts stated here 
under.  
 I state that I came to Ragas Dental College Hospital, Chennai for my 
treatment for   ………………………………………………………  
I was examined by Dr. ___________________________ and I was requested 




 I was also informed and explained about the pros and cons of the 
treatment / test in the __________________ (language) known to me. 








 I was also informed and explained that the results of the individual test 
will not be revealed to the public. I give my consent after knowing full 
consequences of the dissertation/ thesis /study and I undertake to cooperate 
with the doctor for the study. 
 I also assure that I shall come for each and every sitting without fail. 
 I also authorize the doctor to proceed with further treatment or any 
other/suitable/alternative method for the study. 
 I have given voluntary consent to undergo treatment without any 
individual pressure. 
 I am also aware that I am free to withdraw the consent at any time 
during the study in writing. 
 
Signature of the Patient/Attendant 
 The patient was explained the procedure by me and he has understood 
the same and with full consent signed in (English/ Tamil/ Hindi/ Telugu/ 
____________) before me. 
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 The present study was done to assess the circulatory and salivary 
cytokine levels of TNF alpha and IL-4 in patients with periodontal health and 
disease and correlate them with a non-specific systemic inflammatory marker, 
hs-CRP. 
 30 peripheral blood samples and saliva samples were collected from 
the 2 groups - Group A and Group B (15 periodontal health and 15 periodontal 
disease). Cytokine levels in serum and saliva were assessed using sandwich 
ELISA technique. Absorbance was measured at 450nm as primary wavelength 
and 650 as reference wave length in terms of pg/ml, and the results were 
obtained. 
Evaluation of serum and salivary levels of TNF alpha in periodontal 
health and disease  
The mean salivary TNF alpha level in periodontal disease was 
209.36±20.63pg/ml whereas the mean salivary TNF alpha level in periodontal 
health was 136.08±25.01 pg/ml. There was a significant increase in the 
periodontal disease when compared to health at P=0.035, P< 0.05 
The mean serum TNF alpha level in periodontal disease was 
77.82±14.79 pg/ml and the mean serum TNF alpha level in periodontal health 






periodontal disease when compared to health at P=0.920, P>0.05 [refer table 
no:1 and graph no:1 ] 
Correlation between salivary and circulatory TNF alpha levels in 
periodontal disease 
There was no significant correlation between the levels of TNF alpha 
in saliva and circulation at P=0.175(P>0.01) (refer table no:3) 
Evaluation of salivary and serum levels of IL-4 in periodontal health and 
disease  
The mean salivary IL-4 level in periodontal disease was 0.82±0.26 
pg/ml whereas the mean salivary IL-4 level in periodontal health was 
1.18±0.29 pg/ml. Though IL-4 level was decreased in disease, the difference 
was not statistically significant when compared to health at P=0.22, P>0.05 
The mean serum IL-4 level in periodontal disease was 1.12±0.21 pg/ml 
and the mean serum IL-4 level in periodontal health was 1.38±0.13pg/ml 
which was not statistically significant at P=0.325, P>0.05 [refer table no:2 and 
Ghraph no:2] 
Correlation between salivary and circulatory IL-4 levels in diseases 
There was no significant correlation between the levels of IL-4 in 






Evaluation of serum and salivary hs-CRP in Periodontal Health and 
Disease 
The mean salivary hs-CRP level in periodontal disease was 1.024±0.19 
pg/ml and the mean salivary hs-CRP levels in periodontal health was   
0.83±0.18 pg/ml, which was not statistically significant at P= 0.471, P>0.05. 
The mean serum hs-CRP level in periodontal disease was 2.05±0.28 
pg/ml and the mean serum hs-CRP levels in periodontal health was   
1.42±0.21 pg/ml, which was not statistically significant at P= 0.103, 
P>0.05.[refer table no03] 
Correlation of hs-crp to the serum and salivary levels of cytokines (TNF-α 
and IL-4)   
No significant correlation was found between hs-crp and the 
circulatory and salivary levels of the cytokines, except for salivary hs-CRP 
and serum levels of TNF alpha, where a statistically significant correlation 
was found at P=0.727(P>0.01). [refer table no:3] 
 
GRAPH 1  
COMPARISON OF SERUM AND SALIVARY LEVELS OF TNF ALPHA 
IN HEALTH AND DISEASES. 
 
GRAPH 2 
COMPARISON OF SERUM AND SALIVARY LEVELS OF IL-4 IN 
























COMPARISON OF SERUM AND SALIVARY LEVELS OF TNF ALPHA 
IN HEALTH AND DISEASES 
 Mean +std error 
mean in health 
Mean +std error 
mean in diseases 
P value 
SERUM 76.1392 ± 7.4467 77.8283 ±14.7860 P=0.920,p>0.05 
SALIVA 136.0757±20.6350 209.3643±25.0162          0.035p<0.05 
  
TABLE 2 
COMPARISON OF SERUM AND SALIVARY LEVELS OF IL-4 IN 
HEALTH AND DISEASES 
 Mean +std error 
mean in health 
Mean +std error 
mean in diseases 
P value 
SERUM 1.3760±0.1355 1.1210±0.2122 P=0.325, p>0.05 











1 .081 .357 .071 .727(**) 
 Sig. (2-tailed) . .775 .175 .800 .001 
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Periodontal diseases is reported to be a chronic inflammatory condition 
that may, if left untreated, eventually result in tooth loss.
85
 This low grade 
inflammation has also been associated with systemic effects which modulate 
the course of other diseases such as atherosclerosis, diabetes mellitus etc.
76 
An “inappropriate” cytokine milieu into periodontal tissues is thought 
to be one of the pathophysiological pathways that lead to destruction of 
periodontal tissues.
51 
This is also thought to be an important biological 
mechanism through which periodontal diseases mediates its systemic effects. 
Inappropriate cytokine release is generally believed to be a result of an 
imbalance between destructive pro inflammatory and protective anti-
inflammatory cytokines. This study was hence undertaken to evaluate the 
imbalance between pro inflammatory cytokine TNF alpha and anti-
inflammatory cytokine IL-4 in both saliva and circulation and correlate this 
with the inflammatory marker, hs-CRP in chronic periodontitis patients and 
periodontaly healthy subjects. 
The use of saliva as a diagnostic medium has attracted much attention 
over the decades. The lack of site specificity, greater inter individual 
variability and its second hand state (constituents being primarily from GCF) 
were thought to be its disadvantage as a marker. 
In recent years there has been an interest in research on salivary 
diagnosis with identification of the salivary proteome and transcriptome using 






demonstrated that the serum proteome panel that consists of over 2690 
different proteins are almost completely present in saliva.
71
 This has lead to 
the development of lab on chip applications wherein saliva is used as a 
medium for detection of several chronic oral and systemic inflammatory 
diseases like atherosclerosis, diabetes mellitus.
105 
The ease of collection, less 
demand on trained personnel and infrastructure are advantages of saliva over 
GCF. However it must be recognized that for detection of periodontal diseases 
most salivary constituents are obtained from GCF.
25
 
The present study was cross sectional in nature where the salivary 
cytokine levels were assessed in both chronic periodontitis patients and 
healthy controls. The disease group included patients with severe chronic 
periodontitis, the sub classification of mild and moderate were avoided. These 
subdivisions were excluded to avoid confounders in the cytokine profile 
arising from the clinical staging of periodontal disease. Saliva samples were 
all collected between 11A.M and 1 PM as circadian variations are reported to 
affect salivary protein content.
101 
All samples collected were centrifuged at 
2600rpm for 10 minutes and the supernatants were collected to avoid 
contamination. The samples were stored at -80°c to prevent any loss of antigen 
as per well established protocol.
99 
Enzyme-linked immunosorbent assay (ELISA) is used in both 
experimental and diagnostic techniques. It is a highly sensitive assay that can 
detect proteins at the picomolar to nanomolar range (10-12 to 10-9 moles per 
liter)as per the studies reported by Ruo-Pan Huang et al.
97 






used in our study as high sensitivity to detect proteins can be achieved with 
less laboratory demands, thereby reducing cost. Techniques such as Real Time 
PCR, NMR etc provide greater ability to detect minute quantities of protein 
but they are expensive and extensive, placing them beyond the reach of the 
socio economically challenged sections of our population.  
The results of this study suggested that there was a marginal decrease 
in IL-4 levels in periodontal disease when compared to health but the 
difference was not statistically significant. 
IL-4 is known to be an anti-inflammatory cytokine that exerts its 
effects on several inflammatory events.IL-4 is primarily a Th2 cytokine that is 
particularly involved in differentiation of Bcells and Th2 cells. IL-4 is known 
to suppress the Th1 cytokine levels by, firstly, exerting a direct antagonistic 
effect on IFN which is a signature cytokine for Th1 cell,
97
 by down regulating 
the master transcription factor T-bet of Th1 cells
106 
and thirdly by affecting the 
epigenetic mechanism that may influence the DNA methylation involved in T 
cell differentiatio.
113 
A reduction in IL4 levels is therefore thought to be 
associated with increased Th1 activity, macrophagic conversion to osteoclasts 
and consequently disease progression.
54 
Therefore, down regulation of anti-




These results were comparable to the study conducted by Teles et al 
where a statistically insignificant difference in the salivary IL-4 levels were 








Similarly, Ivaniushko TP et al  reported a decrease in the levels of IL-4 while 
there was an increase in THF alpha in saliva samples of patients with chronic 
periodontitis.
43 
There was a statistically significant increase in the salivary levels of 
TNF alpha in the periodontal disease samples when compared to the health 
samples in our study.
 
TNF alpha is one of the key cytokines that plays an important role in 
the pathogenesis of periodontal diseases. It is produced mainly by 
macrophages in response to agents such as lipopolysaccharide.
18
 The release 
of TNF alpha during an inflammatory process mediates increased expression 
of cell adhesion molecules like VCAM-1, ICAM-1 on the vascular endothelial 
cells that will lead to increased infiltration of leukocytes into the periodontal 
tissues. It promotes adhesion of immune cells to endothelial cells and causes 
an increase in vascular permeability.
57,59
 It also acts as a chemotactic cytokine 
which helps in increased cell migration into the inflamed area.
22 TNFα can 
initiate apoptosis by stimulating many cell types by the recruitment of the 
DED containing protein caspase-8 to the receptor complex following 
association of TRADD & FADD to TNRF-1. This receptor recruitment results 
in autocatalytic activation of caspase-8. It then initiates a series of caspase 
activation steps culminating in the activation of effector caspase like caspase-
3. TNF alpha up regulates the expression of RANKL and thereby leads to 
increased osteoclastogenisis and contributes to the increased bone loss seen in 
periodontal diseases.
74






tissue destruction as it mediates the release of  collagenase and degradation of 
type 1 collagen by fibroblasts.
64 
Considering the key role this cytokine plays in 
mediating the disease process, the significant increase observed in 
periodontitis samples was along expected lines. 
Our results were in accordance with Frodge et al, who found an 
increase in the levels of salivary TNF alpha in chronic periodontitis patients 
compared to health.
30 
The results of our study indicate that there was no significant 
difference in the circulating TNF alpha and IL 4 levels between periodontal 
health and disease. This would indicate that there is not much release of TNF 
alpha or IL4 released into the circulation in periodontal disease. Although 
most literature would seem to suggest otherwise, a previous study by 
Nakajima T et al had reported a significantly lower level of TNF alpha in 
serum of periodontitis patients compared to control.
72 
Our results would seem 
to follow this study more closely as against those of Anthony M. Iacopino
5
 
who demonstrated that periodontitis-induced bacteremia/endotoxemia causes 
elevations of serum pro inflammatory cytokine tumor necrosis factor-alpha 
(TNF-α). 
There was no significant correlation between saliva and circulatory 
interleukin levels in our study. Whole saliva is a mixture of oral fluids and 
includes secretions from both the major and minor salivary glands, several 
constituents of non-salivary origin, such as gingival crevicular fluid, 






oral wounds, bacteria and bacterial products, viruses and fungi, desquamated 
epithelial cells, other cellular components, and food debris.
63 
Therefore, it is  
entirely possible that the salivary interleukin level may well correlate better 
with its levels in GCF than in serum. This may explain the reason why there 
was no correlation between the salivary and serum cytokine levels in our 
study. 
Our  results are in agreement with those of Fiorini T, has reported that 
the GCF levels of TNF alpha did not well correlate with that of serum.
27 
Although this study was performed on GCF samples, the results may be 
extrapolated to our study because GCF may the main source of salivary 
constituents in periodontal disease, as previously indicated. 
 
CRP is considered as a systemic biomarker of inflammation and plays 
a direct role in the pathogenesis of inflammation. Pasceri et al found that CRP 
directly induces the expression of adhesion molecules by endothelial cells.
89
 
Presence of acute phase protein in immunological response of periodontitis  is 
thought to confirm the involvement of a systemic inflammatory response.
58 
 
This acute-phase reactants have pro-inflammatory properties wherein they 
help to neutralize pathogens in the periodontal environment and stimulate 
repair and regeneration of tissues. CRP has been focused in many studies   
because its elevated levels constitute a risk factor for cardiovascular disease 
(CVD) and for chronic inflammatory conditions like diabetes mellitus.
13 
Several reports have demonstrated elevated serum CRP levels in patients with 
periodontitis compared with healthy controls.
92 






reported that the circulatory levels of hs-CRP significantly correlated with 
severity of periodontitis.
87 
Craig RG determined the effect of destructive 
periodontal disease status, severity and progression on components of the 
acute-phase response and found that destructive periodontal disease and 
disease progression are consistent with increase in serum components of 
hsCRP.
19 
Most of the reported literature is related to serum hs-CRP levels, few 
studies have focused on its salivary levels. In the present study the circulatory 
hs-CRP levels were not investigated as we have previously reported on the 
lack of correlation between periodontal disease and circulating hs-CRP levels 
(Dissertation submitted to Dr. M.G.R. UNIVERSITY).  In contradiction to the 
previously mentioned reports, the results of our study showed no correlation in 
salivary hs-CRP levels between periodontal health and disease. These results 
may be explained on the basis that most blood constituents unlike GCF, 
undergo a filtration process in the oral mucosa before they reach saliva. 
Consequently, there is a weaker expression in saliva when compared to blood, 
leading to no statiscally significant difference between health and disease. The 
salivary hs-CRP levels in our study were much lower when compared to the 
serum levels we obtained in a previous study in patients with periodontal 
disease. 
  On the other hand, our study was more in accordance with Yakob et al 
where they investigated circulatory high-sensitivity C-reactive protein                    






periodontitis and found the circulatory levels of hs-CRP was not significantly 
associated with periodontitis.
115
 Offenbecker et al also reported no significant 
reduction in the hs-CRP levels in of chronic periodontitis patients after 6 
months of periodontal treatment.
79
 Another study by Nakajima T  and 
coworkers reported that the concentration of hs-CRP is not affected by 
periodontal treatment although there was an increased concentration of                   
hs-CRP in periodontal infections.
72 
We tried to correlate both the pro and anti inflammatory cytokine 
levels with hs-CRP. The results of our study indicate that there was no 
correlation between the salivary cytokine and hs-CRP. However, there was a 
significant correlation between the TNF alpha level in serum and hs-CRP level 
in saliva.  
This was similar to the study done by Bahceci M, on diabetic patients 
where they demonstrated an association between TNF alpha and hs-CRP 
levels in circulation.
7 
Parks HS and coworkers also demonstrated an 
association of serum TNF alpha and hs-CRP in obese patients with increased 
visceral adiposity.
88 
The implications of these results are not immediately apparent but it 
may be suggested that the nonspecific inflammatory marker salivary hs-CRP 
may correlate with circulating pro inflammatory cytokines, indicating that it 
has value as a surrogate marker in systemic inflammatory disorders. Further 






Taking together, the results of this study indicate that salivary markers 
need to be interpreted with a lot of caution if they are used to detect systemic 
diseases as they may not accurately reflect serum levels. On the other hand, it 
shows some promise as a marker of systemic inflammation. However, salivary 
cytokines may be used to detect periodontal disease with reasonable accuracy 
as there was a statistically significant difference obtained in the TNF alpha 
levels.  
It must be clearly understood that periodontal diseases involve 
interaction of various cytokines that take part in the inflammatory process. 
Hence analysis of a few cytokines would not depict the progression of 
inflammatory process in the periodontal tissues. Therefore an array of other 
cytokines that are released into the periodontal environment should be 
analyzed to map the pathogenesis that leads to periodontal diseases. Thus a 
panel of salivary cytokines may provide accurate prediction of the periodontal 
disease activity and may be used for diagnostic and prognostic purposes.  
The cross sectional study design may minimize the strength of 
evidence as the limited samples size may not represent the entire population 
from where they are drawn, may provide differing results if another time 
frame is chosen and is prone for Neyman bias.
14 
Hence further studies are 
required to asses multiple cytokine profile in periodontal diseases to predict 
the progression of diseases and therapeutic outcome of the periodontal 






of saliva in comparison with that of other biomedia will be necessary to assess 
the disease discriminatory value of saliva.
20
  
Within the limitations of the study, these results demonstrate both the 
value of salivary diagnostics in periodontal disease and its limitations in 




















SUMMARY AND CONCLUSION 
The aim of the present study was to estimate the circulatory and 
salivary levels of inflammatory cytokines TNF alpha and IL-4 between 
periodontal health and disease and to assess whether they correlate with each 
other and with the systemic inflammatory marker, hs-CRP. 30 patients who 
attended the outpatient Department of periodontology, Ragas Dental College 
and Hospitals, Chennai were enrolled in the study.   Patients were divided in to 
two groups based on their periodontal health status- 15 periodontaly healthy 
patients, 15 Periodontitis patients. 
Peripheral blood and saliva was collected prior to phase I periodontal 
therapy from these patients and processed for ELISA analysis. Processing for 
ELISA involved the preparation of serum from peripheral blood.  
Statistical analysis was done using independent sample student T test 
and pearson correlation test. 
From the results of this study, we may conclude that 
1) The significantly increased levels of pro inflammatory cytokine TNF 
alpha in chronic periodontitis patients indicates that it may be used as a 
marker for chronic periodontitis. 
2) Salivary and circulating levels of cytokines TNF alpha, IL4 do not 
correlate with each other. 





3) Salivary levels of hs-CRP may not prove to be an ideal marker of 
ongoing inflammation associated with periodontal diseases; it may 
instead reflect serum pro inflammatory cytokine levels. 
Further long term studies with an array of cytokines conducted on a 
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